Research Analysts Issue Forecasts for Mettler-Toledo International Inc.’s Q4 2025 Earnings (NYSE:MTD)

Mettler-Toledo International Inc. (NYSE:MTDFree Report) – Investment analysts at Zacks Research decreased their Q4 2025 earnings per share (EPS) estimates for Mettler-Toledo International in a research note issued to investors on Monday, July 22nd. Zacks Research analyst R. Department now forecasts that the medical instruments supplier will post earnings of $12.50 per share for the quarter, down from their previous forecast of $12.52. The consensus estimate for Mettler-Toledo International’s current full-year earnings is $40.13 per share. Zacks Research also issued estimates for Mettler-Toledo International’s Q1 2026 earnings at $10.99 EPS.

A number of other brokerages also recently issued reports on MTD. Jefferies Financial Group reissued an “underperform” rating and issued a $1,250.00 price target (up from $1,230.00) on shares of Mettler-Toledo International in a research report on Monday, June 3rd. The Goldman Sachs Group lifted their price objective on shares of Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 9th. Stifel Nicolaus increased their price target on shares of Mettler-Toledo International from $1,270.00 to $1,510.00 and gave the stock a “buy” rating in a report on Monday, May 13th. Evercore ISI boosted their price objective on Mettler-Toledo International from $1,375.00 to $1,390.00 and gave the company an “in-line” rating in a report on Tuesday, July 2nd. Finally, StockNews.com raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Thursday, July 11th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $1,301.25.

View Our Latest Analysis on MTD

Mettler-Toledo International Stock Performance

Shares of NYSE MTD opened at $1,384.56 on Thursday. The stock has a 50 day moving average price of $1,419.26 and a 200 day moving average price of $1,313.29. Mettler-Toledo International has a 52-week low of $928.49 and a 52-week high of $1,535.86. The firm has a market capitalization of $29.57 billion, a price-to-earnings ratio of 38.83, a PEG ratio of 3.65 and a beta of 1.17.

Mettler-Toledo International (NYSE:MTDGet Free Report) last posted its quarterly earnings data on Thursday, May 9th. The medical instruments supplier reported $8.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.61 by $1.28. Mettler-Toledo International had a negative return on equity of 662.32% and a net margin of 20.55%. The company had revenue of $925.95 million during the quarter, compared to analysts’ expectations of $879.72 million. During the same quarter in the previous year, the business earned $8.69 EPS. Mettler-Toledo International’s revenue was down .3% compared to the same quarter last year.

Insider Transactions at Mettler-Toledo International

In related news, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $1,528.43, for a total transaction of $458,529.00. Following the transaction, the chief financial officer now owns 4,914 shares in the company, valued at $7,510,705.02. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other Mettler-Toledo International news, Director Thomas P. Salice sold 1,268 shares of Mettler-Toledo International stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $1,490.18, for a total value of $1,889,548.24. Following the completion of the transaction, the director now directly owns 244 shares of the company’s stock, valued at approximately $363,603.92. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Shawn Vadala sold 300 shares of the business’s stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $1,528.43, for a total transaction of $458,529.00. Following the completion of the transaction, the chief financial officer now owns 4,914 shares of the company’s stock, valued at approximately $7,510,705.02. The disclosure for this sale can be found here. Insiders sold 3,278 shares of company stock valued at $4,871,849 over the last 90 days. 1.94% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Mettler-Toledo International

Several hedge funds and other institutional investors have recently made changes to their positions in MTD. CVA Family Office LLC acquired a new stake in Mettler-Toledo International in the fourth quarter valued at $27,000. Raymond James Financial Services Advisors Inc. raised its stake in shares of Mettler-Toledo International by 25.4% in the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 1,676 shares of the medical instruments supplier’s stock valued at $2,033,000 after acquiring an additional 340 shares during the period. Values First Advisors Inc. lifted its holdings in Mettler-Toledo International by 2.6% in the 4th quarter. Values First Advisors Inc. now owns 1,139 shares of the medical instruments supplier’s stock worth $1,382,000 after buying an additional 29 shares in the last quarter. Caprock Group LLC boosted its holdings in Mettler-Toledo International by 450.2% in the fourth quarter. Caprock Group LLC now owns 1,733 shares of the medical instruments supplier’s stock valued at $2,102,000 after purchasing an additional 1,418 shares during the last quarter. Finally, Patron Partners LLC grew its position in shares of Mettler-Toledo International by 1.3% during the fourth quarter. Patron Partners LLC now owns 1,368 shares of the medical instruments supplier’s stock worth $1,659,000 after buying an additional 18 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

(Get Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems.

Featured Stories

Earnings History and Estimates for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.